INBP · Integrated Biopharma Inc
Market Cap
$5.59M
Shares
31.06M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.18
Open$0.18
Day$0.18–0.18
52W close$0.15–0.38
Avg vol 30d7K
Short int2K · 0.0% float · 1.0d
Short vol57%
DataJan 2020–Sep 2026
Filing10-Q · May 8
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−33%
below
Price vs 50-day avg
+2%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
13%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+13%
trailing
6-month return
−47%
trailing
YTD return
−50%
this year
Relative strength
−60%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -11.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−7%
Y/Y
Gross margin
13%
expanding
Free cash flow
$1.9M
Balance sheet
$1.3M
net cash
Quant / Vol
risk profile
Volatility
77%
annualized · 1-yr
Max drawdown
−61%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−33%
Bearish
Price vs 50-day avg
+2%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
13%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -11.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 13%
Range high $0
vs 200-day avg -33%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INBP
this stock
Integrated Biopharma Inc
|
$5.59M | -50.0% | -6.9% | — | 0.0% |
|
KHC
Kraft Heinz Co
|
$30.68B | +6.7% | -0.1% | — | 7.2% |
|
GIS
General Mills Inc
|
$21.93B | -11.6% | +4.1% | — | 8.4% |
|
MKC
Mccormick & Co Inc
|
$14.88B | -20.3% | +1.7% | 9.2 | 4.9% |
|
JBS
Jbs N.V.
|
$14.36B | -7.0% | — | — | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INBP | +3.5% | +12.5% | -47.1% | -5.3% | -50.0% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | +4.0% | +13.7% | -59.7% | -4.6% | -61.7% |